FdaApplication
NDA 214373
Identifiers
- fda_app_no: NDA214373
Properties
| Property | Value |
|---|---|
| applicant_name | THERACOSBIO LLC |
| application_type | NDA |
| approval_date | 2023-01-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BRENZAVVY | BEXAGLIFLOZIN | 20MG | TABLET;ORAL |
1 product